Sanqi An

558 total citations
32 papers, 273 citations indexed

About

Sanqi An is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sanqi An has authored 32 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Sanqi An's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (5 papers). Sanqi An is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (5 papers). Sanqi An collaborates with scholars based in China, United States and South Korea. Sanqi An's co-authors include Hao Liang, Li Ye, Yaxin Chen, Junjun Jiang, Wanxu Huang, Weisheng Cheng, Xiang Huang, Jinkai Wang, Xiang Sun and Wenfang Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Cancer Research.

In The Last Decade

Sanqi An

26 papers receiving 269 citations

Peers

Sanqi An
Si’Ana A. Coggins United States
Josefine Striepen United States
Baojun Wei China
Du Cheng China
Olivier Delfour France
Artur A. Serebrenik United States
Jeffrey R. Johnson United States
Chengcheng Zou China
Gopinath Ganji United States
Si’Ana A. Coggins United States
Sanqi An
Citations per year, relative to Sanqi An Sanqi An (= 1×) peers Si’Ana A. Coggins

Countries citing papers authored by Sanqi An

Since Specialization
Citations

This map shows the geographic impact of Sanqi An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanqi An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanqi An more than expected).

Fields of papers citing papers by Sanqi An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanqi An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanqi An. The network helps show where Sanqi An may publish in the future.

Co-authorship network of co-authors of Sanqi An

This figure shows the co-authorship network connecting the top 25 collaborators of Sanqi An. A scholar is included among the top collaborators of Sanqi An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanqi An. Sanqi An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
An, Sanqi, et al.. (2025). Phase separation in mitochondrial fate and mitochondrial diseases. Proceedings of the National Academy of Sciences. 122(21). e2422255122–e2422255122. 1 indexed citations
2.
Lee, Shiou Yih, et al.. (2025). StomachDB: An Integrated Multi-Omics Database for Gastric Diseases. Biology. 14(11). 1484–1484.
3.
An, Sanqi, et al.. (2025). Moonlighting functions of phosphoglycerate dehydrogenase in cancer. Cell Reports. 44(7). 115940–115940.
4.
Chen, Shanshan, F. Chen, Jie Liu, et al.. (2025). Forsythoside B activates Siglec-14 to inhibit HIV-1 replication via the JAK1/STAT1 pathway. International Journal of Biological Macromolecules. 303. 140632–140632.
5.
Liang, Shuaiyi, et al.. (2024). Pan-cancer Analysis Reveals m6A Variation and Cell-specific Regulatory Network in Different Cancer Types. Genomics Proteomics & Bioinformatics. 22(4). 14 indexed citations
6.
An, Sanqi, et al.. (2024). The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases. Biomolecules. 14(9). 1056–1056. 8 indexed citations
7.
Li, Yue-Qi, Wenxing Li, Shuaiyi Liang, et al.. (2024). Scm6A: A Fast and Low-cost Method for Quantifying m6A Modifications at the Single-cell Level. Genomics Proteomics & Bioinformatics. 22(4). 1 indexed citations
8.
Zhou, Lijuan, Hailong Wang, Yanyan Liao, et al.. (2024). Deep Learning-driven Identification and Evaluation of Potential Therapeutic Agents for COVID-19 Co-infection Diseases Targeting METTL3. Letters in Drug Design & Discovery. 22. 1 indexed citations
9.
Qin, Jiao, Fei Zhang, Xi Chen, et al.. (2024). Willingness to accept monkeypox vaccine and its correlates among men who have sex with men in Southern China: a web-based online cross-sectional study. Frontiers in Public Health. 12. 1289918–1289918. 7 indexed citations
10.
Chen, Yaxin, Jingyi Li, Wudi Wei, et al.. (2024). Dynamic m 6 A profiles reveal the role of YTHDC2‐TLR2 signaling axis in Talaromyces marneffei infection. Journal of Medical Virology. 96(2). e29466–e29466. 4 indexed citations
11.
Wei, Wudi, Hong Zhang, Sanqi An, et al.. (2023). Talaromyces marneffei suppresses macrophage inflammation by regulating host alternative splicing. Communications Biology. 6(1). 1046–1046. 4 indexed citations
12.
He, Ke, et al.. (2023). Integrative analysis of multi-omics data reveals inhibition of RB1 signaling promotes apatinib resistance of hepatocellular carcinoma. International Journal of Biological Sciences. 19(14). 4511–4524. 3 indexed citations
13.
Li, Yueqi, Jingyi Li, Hailong Wang, et al.. (2023). Weighted gene co-expression network analysis revealed T cell differentiation associated with the age-related phenotypes in COVID-19 patients. BMC Medical Genomics. 16(1). 59–59. 3 indexed citations
14.
Chen, Yaxin, Gang Wang, Jingyi Li, et al.. (2022). CASA: a comprehensive database resource for the COVID-19 Alternative Splicing Atlas. Journal of Translational Medicine. 20(1). 473–473. 4 indexed citations
15.
16.
He, Ke, Yuliang Feng, Sanqi An, Fei Liu, & Guoan Xiang. (2021). Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatic cholangiocarcinoma. Genomics. 114(1). 241–252. 6 indexed citations
17.
An, Sanqi, Yueqi Li, Jinming Su, et al.. (2021). Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19. Frontiers in Immunology. 12. 756288–756288. 24 indexed citations
18.
An, Sanqi, Wanxu Huang, Xiang Huang, et al.. (2019). Integrative network analysis identifies cell-specific trans regulators of m6A. Nucleic Acids Research. 48(4). 1715–1729. 63 indexed citations
19.
20.
Yang, Dong, Bin Sun, Xiaohong Zhang, et al.. (2017). Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3- H19 Cascade. Cancer Research. 77(18). 4773–4784. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Si’Ana A. Coggins Breakdown of academic impact, for papers by Josefine Striepen Breakdown of academic impact, for papers by Baojun Wei Breakdown of academic impact, for papers by Du Cheng Breakdown of academic impact, for papers by Olivier Delfour Breakdown of academic impact, for papers by Artur A. Serebrenik Breakdown of academic impact, for papers by Jeffrey R. Johnson Breakdown of academic impact, for papers by Chengcheng Zou Breakdown of academic impact, for papers by Gopinath Ganji
Rankless by CCL
2026